Adagene (ADAG) Operating Leases (2022 - 2025)

Adagene's (ADAG) quarterly Operating Leases came in at $53.5 billion in Q4 2025, down 62.42% year-on-year from $142.3 billion in Q4 2024, and up 60289624.37% on a QoQ basis from $88705.0 in Q2 2025.

Adagene (ADAG) Operating Leases (2022 - 2025) Analysis & Trends

Adagene (ADAG) has 4 years of Operating Leases data on file, last reported at $53.5 billion in Q4 2025.

  • On a quarterly basis, Operating Leases fell 62.42% year-over-year to $53.5 billion in Q4 2025; TTM through Dec 2025 was $53.5 billion, a 62.42% decrease from a year earlier, with the FY2025 full-year figure at $53.5 billion, down 62.42% from the prior year.
  • Operating Leases for Q4 2025 stood at $53.5 billion, up from $88705.0 in the prior quarter.
  • Over the last five years, Operating Leases for ADAG reached as high as $173.7 billion in Q4 2023 and fell as low as $88705.0 in Q2 2025.
  • Historically, Operating Leases has averaged $86.6 billion across 4 years, with a median of $91.0 billion in 2022.
  • Across the five-year window, Operating Leases soared 222.58% in 2023 and tumbled 100.0% in 2024, its largest moves.
  • Year by year, Operating Leases stood at $53.8 billion in 2022, then surged by 222.58% to $173.7 billion in 2023, then decreased by 18.06% to $142.3 billion in 2024, then slumped by 62.42% to $53.5 billion in 2025.
  • Per Business Quant data, the three most recent Operating Leases figures were $53.5 billion in Q4 2025, $88705.0 in Q2 2025, and $142.3 billion in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Adagene 198.85 Mn 198.85 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 53.48 Bn
Jun 30, 2025 88,705.00
Dec 31, 2024 142.30 Bn
Jun 30, 2024 114,086.00
Dec 31, 2023 173.66 Bn
Jun 30, 2023 141.43 Bn
Dec 31, 2022 53.83 Bn
Jun 30, 2022 128.08 Bn